Dr Siân Lax BSc (Hons), PhD

Dr Siân Lax

Cancer Research UK Clinical Trials Unit
Clinical Trial Facilitator

Contact details

Address
Cancer Research UK Clinical Trials Unit (CRCTU)
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Siân Lax’s current role is within the Cancer Research UK Clinical Trials Unit (CRCTU) where she acts as the first point of contact for clinical investigators wishing to work with the CRCTU.

Qualifications

  • PhD in Biochemistry, 2004
  • BSc (Hons) in Molecular and Cellular Biochemistry, 2001

Biography

As the Clinical Trial Facilitator, Siân, manages the CRCTU New Business process and provides assistance in obtaining research grants and contributes to writing clinical trial essential documents, publications and reports.

Before working at the CRCTU, Siân was a post-doctoral research fellow working in Professor Steve Watson’s Platelet Group, understanding the role of the platelet receptor CLEC-2 in regulating the severity of acute lung injury using in vivo models of lung inflammation and injury. Her previous post-doctoral work involved elucidating the in vivo role of hormones in lung injury and the role of mesenchymal stromal cells in lymphoid tissues following infection. Siân obtained her PhD from University of Birmingham in 2004 researching the function of Rho-kinase II in regulated keratinocyte differentiation.

Publications

Recent publications

Article

Ali, S, Zhang, Q, Anwunah, I, Baig, S, Da Silva Xavier, G, Dawson, C, Dassie, F, Tang, Y, Wang, L, Chang, G, Gleeson, P, Warfield, AT, Paisey, RB, Barrett, TG, Maffei, P, Wang, X, Homer, V, Kershaw, M, Geberhiwot, T & Lax, S 2026, 'Defining Puberty and Spectrum of Hypogonadism in Alström Syndrome', Journal of Clinical Endocrinology and Metabolism, vol. 111, no. 1, pp. 33-44. https://doi.org/10.1210/clinem/dgaf356

Brandon, AM, Huisman-Siebinga, H, Barnett, S, Wetherell, P, Kearns, P, Gibson, B, Heaney, N, Smith, O, Baruchel, A, Petit, A, Moore, A, Ogungbenro, K, Huitema, ADR, Veal, GJ & Lax, S 2026, 'Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemia', British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70436

van der Pol, H, Kringelbach, T, Agudo, MM, Stav, GB, Fagereng, GL, Fiocco, M, Falk, RS, Homer, V, Mohammad, SH, Timmer, H, Verlingue, L, Helland, Å, Rohrberg, K, Lassen, U, Halford, S, Jalkanen, K, Juslin, T, Krebs, MG, Oliveira, J, Baltruškevičienė, E, Ojamaa, K, Taskén, K, Gelderblom, H & on behalf of the PRIME-ROSE Consortium 2026, 'Procedures of data merging in precision cancer medicine: the PRIME-ROSE project', Acta Oncologica, vol. 65, pp. 1-8. https://doi.org/10.2340/1651-226X.2026.44889

Keaveney, S, Pratt, G & Lax, S 2025, 'An open-source repository-based tool for quality control of imaging protocol compliance: demonstration in a multicentre MRI study', British Journal of Radiology, vol. 98, no. 1172, pp. 1236–1244. https://doi.org/10.1093/bjr/tqaf089

Moiemen, N, Homer, V, Nice, L, Brock, K, Jenkins, S, Altarrah, K, Imran, R, Tullie, S, Barton, D & Lax, S 2025, 'Efficacy and optimal dose of acetic acid for treating colonised burns wounds (AceticA): a double-blind, single Centre, randomised, controlled phase II trial', Journal of Burn Care and Research. https://doi.org/10.1093/jbcr/iraf228

McIlroy, G, Gaskell, C, Jackson, A, Yafai, E, Tasker, R, Thomas, C, Fox, S, Boucher, R, Ghebretinsea, F, Harrison, C, Mead, AJ, McMullin, MF & Lax, S 2025, 'Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial', BMC Cancer, vol. 25, 56. https://doi.org/10.1186/s12885-024-13383-3

Kirkwood, AA, Goulden, N, Moppett, J, Samarasinghe, S, Hough, R, Rowntree, C, Lawson, S, Kearns, P, Lawson, A, Vora, A & Lax, S 2025, 'High-dose methotrexate in children and young adults with ALL and lymphoblastic lymphoma: Results of the randomized phase III study UKALL 2011', Journal of Clinical Oncology , vol. 43, no. 15, pp. 1810-1823. https://doi.org/10.1200/JCO-24-01851

Steven, NM, Pirrie, S, Jefferson-Hulme, Y, Gaunt, CH, Homer, V & on behalf of the Trial Management Group 2025, 'Rational treatment selection for primary Merkel Cell Carcinoma: a Rational MCC RCT comparing surgery and radiotherapy with parallel observational study', Efficacy and Mechanism Evaluation, vol. 12, no. 12. https://doi.org/10.3310/EEWD6684

Dias, RP, Brock, K, Hu, K, Gupta, R, Martin, U, Peet, A, Wilson, M, Yu-Wai-Man, P, Wright, B, Mollan, S, Kulkarni, A, Meunier, I, Billingham, L, Nagy, Z, Rose, H, Koks, S, Zatyka, M, Astuti, D, Lynch, T, Morrison, KE, Barton, D, Cronier, S, Malpass, R, Evans, R, Malhi, A, Takhar, P, Lamb, A, Esteban-Bueno, G, Młynarski, W, Orssaud, C, Roubertie, A, Homer, V, Barrett, T & Lax, S 2025, 'Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial', BMJ open, vol. 15, no. 2, e091495. https://doi.org/10.1136/bmjopen-2024-091495

Bhaskaran, D, Savage, J, Patel, A, Collinson, F, Mant, R, Boele, F, Brazil, L, Meade, S, Buckle, P, Lax, S, Billingham, L & Short, S 2024, 'A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): Protocol for a multi-centre, double-blind, placebo-controlled trial', BMC Cancer, vol. 24, 83. https://doi.org/10.1186/s12885-023-11792-4

Kong, A, Kirkham, AJ, Savage, JS, Mant, R, Lax, S, Good, J, Forster, MD, Sacco, JJ, Schipani, S, Harrington, KJ, Yap, C & Mehanna, H 2024, 'Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancer', BJC Reports, vol. 2, no. 1, 6. https://doi.org/10.1038/s44276-023-00026-6

Hirschfield, G, Arndtz, K, Kirkham, A, Chen, Y-Y, Fox, R, Rowe, A, Douglas-Pugh, J, Thorburn, D, Barnes, E, Aithal, GP, Hull, D, Bhandal, K, Olsen, K, Woodward, P, Lax, S, Newsome, P, Smith, D, Kallio, A, Adams, D, Homer, V & Weston, C 2024, 'Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: open-label, multi-centre, single arm, phase II trial', Hepatology Communications, vol. 8, no. 5, e0426. https://doi.org/10.1097/HC9.0000000000000426

Letter

Lawson, A, Kearns, P, Moorman, AV & Lax, S 2025, 'Benchmarking the paediatric T-cell ALL subtype classifier, TALLSorts', British Journal of Haematology. https://doi.org/10.1111/bjh.70263

Lorde, N, Pratt, G, Geberhiwot, T, Ayuk, J, Gittoes, N & Lax, S 2025, 'Paraprotein-Induced spurious hypercalcaemia: Diagnostic pitfalls in two cases', European Journal of Endocrinology, vol. 193, no. 2, pp. K1-K4. https://doi.org/10.1093/ejendo/lvaf151

Review article

Hemming, K, Thompson, J, Kristunas, C, Forbes, A, Watson, S, Bowden, R, McKenzie, JE, Kasza, J & Lax, S 2025, 'The performance of small sample correction methods for controlling type I error when analyzing parallel cluster randomized trials: a systematic review of simulation studies', Journal of Clinical Epidemiology, vol. 185, 111838. https://doi.org/10.1016/j.jclinepi.2025.111838

View all publications in research portal